Dixit, Karan S http://orcid.org/0000-0003-0403-6054
Sachdev, Sean
Amidei, Christina
Kumthekar, Priya
Kruser, Tim J
Gondi, Vinai
Grimm, Sean
Lukas, Rimas V
Nicholas, Martin Kelly
Chmura, Steven J
Fought, Angela J
Mehta, Minesh
Raizer, Jeffrey J
Article History
Received: 12 August 2021
Accepted: 11 October 2021
First Online: 24 October 2021
Declarations
:
: All authors have no conflicts of interest to report in regard to this manuscript except for the following listed. MM reports consulting with Mevion, Karyopharm, Tocagen, Astra-Zeneca, and Blue Earth Diagnostics, and serves on the Board of Directors of Oncoceutics (with options). TJK reports personal fees from AstraZeneca (advisory board and speakers bureau) and speaking fees from OncLive. JJR is an employee of Astellas. RML reports research (drug only) from Bristol-Meyer Squibb, Novocure (speakers’ bureau), and honoraria for medical editing from EBSCO Publishing, Medlink Neurology, and American Physician Institute.